Earth Science Tech Inc. (OTC: ETST) is positioning itself as a vertically integrated healthcare company through its subsidiaries RxCompoundStore, Mister Meds, and Peaks Curative. The subsidiaries combine compounding pharmacy services, telemedicine, clinical support, and fulfillment capabilities.

ETST operates across both business-to-business and business-to-consumer channels. Its model serves independent clinics while also providing customized medications directly to consumers, creating revenue streams across physical and digital healthcare operations.

For FY2026, ETST reported revenue of $35.7 million, compared with $33.1 million in FY2025 and $11.95 million in FY2024. The company also reported positive operating cash flow and a stronger balance sheet. Total liabilities declined from $3.146 million to $1.928 million, while assets increased from $7.066 million to $8.969 million. ETST also fully repaid its long-term debt.

The company says it expects operating cash flow to fund its FY2027 needs without additional dilutive financing. That approach reflects its stated strategy of pursuing growth through internally generated cash rather than additional debt or shareholder dilution. As the company moves into FY2027, its ability to support planned operations with operating cash flow will be an important financial measure alongside revenue and balance-sheet changes.

ETST’s integrated model is designed to connect patient care from consultation through fulfillment by combining compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The company says this structure serves both healthcare providers and consumers. The combination of these functions also gives the company a single operating model spanning clinical access, medication preparation, and delivery, rather than relying on only one healthcare service line.

The reported reduction in liabilities, increase in assets, and repayment of long-term debt mark changes to the company’s financial position as it continues operating across its healthcare businesses. ETST’s expectation that operating cash flow will cover FY2027 needs is also part of the company’s stated financing strategy. Continued reporting on revenue, cash flow, liabilities, and the performance of its subsidiaries will show how that strategy develops.

The full article is available at More information about the company is available at The source article was published by Citybuzz at https://www.citybuzz.co/2026/09/10/earth-science-techs-integrated-healthcare-platform-drives-revenue-growth-and-debt-reduction/.

The post “Earth Science Tech’s Integrated Healthcare Platform Drives Revenue Growth and Debt Reduction” originally appeared on Citybuzz.